View in EDS PDF Full Text

Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.

Saved in:
Bibliographic Details
Title: Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.
Authors: Hu LS; Department of Radiology, Mayo Clinic in Arizona, Phoenix, AZ 85054, USA. hu.leland@mayo.edu, Eschbacher JM, Heiserman JE, Dueck AC, Shapiro WR, Liu S, Karis JP, Smith KA, Coons SW, Nakaji P, Spetzler RF, Feuerstein BG, Debbins J, Baxter LC
Source: Neuro-oncology [Neuro Oncol] 2012 Jul; Vol. 14 (7), pp. 919-30. Date of Electronic Publication: 2012 May 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22561797
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hu+LS%22">Hu LS</searchLink>; Department of Radiology, Mayo Clinic in Arizona, Phoenix, AZ 85054, USA. hu.leland@mayo.edu<br /><searchLink fieldCode="AU" term="%22Eschbacher+JM%22">Eschbacher JM</searchLink><br /><searchLink fieldCode="AU" term="%22Heiserman+JE%22">Heiserman JE</searchLink><br /><searchLink fieldCode="AU" term="%22Dueck+AC%22">Dueck AC</searchLink><br /><searchLink fieldCode="AU" term="%22Shapiro+WR%22">Shapiro WR</searchLink><br /><searchLink fieldCode="AU" term="%22Liu+S%22">Liu S</searchLink><br /><searchLink fieldCode="AU" term="%22Karis+JP%22">Karis JP</searchLink><br /><searchLink fieldCode="AU" term="%22Smith+KA%22">Smith KA</searchLink><br /><searchLink fieldCode="AU" term="%22Coons+SW%22">Coons SW</searchLink><br /><searchLink fieldCode="AU" term="%22Nakaji+P%22">Nakaji P</searchLink><br /><searchLink fieldCode="AU" term="%22Spetzler+RF%22">Spetzler RF</searchLink><br /><searchLink fieldCode="AU" term="%22Feuerstein+BG%22">Feuerstein BG</searchLink><br /><searchLink fieldCode="AU" term="%22Debbins+J%22">Debbins J</searchLink><br /><searchLink fieldCode="AU" term="%22Baxter+LC%22">Baxter LC</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2012 Jul; Vol. 14 (7), pp. 919-30. <i>Date of Electronic Publication: </i>2012 May 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22561797
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/nos112
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 919
    Titles:
      – TitleFull: Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hu LS
      – PersonEntity:
          Name:
            NameFull: Eschbacher JM
      – PersonEntity:
          Name:
            NameFull: Heiserman JE
      – PersonEntity:
          Name:
            NameFull: Dueck AC
      – PersonEntity:
          Name:
            NameFull: Shapiro WR
      – PersonEntity:
          Name:
            NameFull: Liu S
      – PersonEntity:
          Name:
            NameFull: Karis JP
      – PersonEntity:
          Name:
            NameFull: Smith KA
      – PersonEntity:
          Name:
            NameFull: Coons SW
      – PersonEntity:
          Name:
            NameFull: Nakaji P
      – PersonEntity:
          Name:
            NameFull: Spetzler RF
      – PersonEntity:
          Name:
            NameFull: Feuerstein BG
      – PersonEntity:
          Name:
            NameFull: Debbins J
      – PersonEntity:
          Name:
            NameFull: Baxter LC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2012 Jul
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1